Dividend Track Records (DTR)

On December 10, 2025, Bristol Myers-Squibb (BMY) announced a 1.6% dividend increase , raising its quarterly payout to $0.63 per share . At a share price of $51.21 , the new dividend represents a forward yield of roughly 4.9% . The company has now achieved 18 consecutive years of dividend growth .

Bristol-Myers Squibb (BMY) will raise its dividend by 3.3 percent to 62 cents per share quarterly in 2025. This brings the dividend track record to 17 consecutive years of increases for the Pharmaceuticals giant.

Bristol-Myers Squibb (BMY) will raise its dividend by 10.2 percent to 54 cents per share quarterly. This comes after a 8.9 percent hike to $0.49 per share announced by BMY in 2021. The pharmaceutical company has now raised its dividend for 14 consecutive years. The next quarterly BMY dividend of 54 cents will be payable on February 1, 2022 to stockholders of record at the close of business on January 7, 2022. A new indicated annual dividend rate of $2.16 per share yields 3.6% at a stock price of $60. Bristol-Myers Squibb now pays an estimated $4.79 billion in dividends to shareholders annually. Dividend growth has been picking up in the last three years, lifting the five year average annualized dividend growth rate to 6.7 percent if we include the 2021 dividend hike just announced. Bristol-Myers Squibb Company is is a global specialty biopharmaceutical company.  Bristol-Myers is developing new medicines in the following core therapeutic areas: oncology with a priority in certain t...

Bristol-Myers Squibb (BMY) will raise its dividend by 8.9 percent to $0.49 per share in 2021. This comes after a 9.8 percent hike to $0.45 quarterly announced by the pharmaceutical company last year. This is the second biggest dividend increase by BMY since 2008. The pharmaceutical company completed the acquisition of biotech company Celgene last year and has now raised its dividend for 13 consecutive years. The next quarterly dividend will be payable on February 1, 2021 to stockholders of record at the close of business on January 4, 2021. A new indicated annual dividend rate of $1.96 per share yields 3.1% at a stock price of $63.12. Bristol-Myers Squibb now pays an estimated $4.4 billion in dividends to shareholders annually. Dividend growth has been picking up in the last two years, lifting the five year average annualized dividend growth rate to 5.2 percent if we include the 2020 dividend hike just announced. Bristol-Myers Squibb Company is is a global specialty biopharmaceutical c...

Bristol-Myers Squibb (BMY) will raise its dividend by 9.8 percent to $0.45 quarterly in the first quarter of 2020. This is the biggest dividend increase by BMY since 2008. The pharmaceutical company just completed the acquisition of biotech company Celgene and has now raised its dividend for 12 consecutive years. The next quarterly dividend will be payable on February 3, 2020, to stockholders of record at the close of business on January 3, 2020. A new indicated annual dividend rate of $1.80 per share yields 3% at a stock price of $59.95. Bristol-Myers Squibb Company is is a global specialty biopharmaceutical company.  Bristol-Myers is developing new medicines in the following core therapeutic areas: oncology with a priority in certain tumor types; immunoscience with priorities in psoriasis, lupus, RA and inflammatory bowel disease;  cardiovascular with a priority in heart disease and; fibrotic disease with priorities in lung and liver. The company's top drugs include Opdi...